News-Medical.net |
Atopix raises additional development capital to investigate OC459 for …
News-Medical.net Atopix Therapeutics Limited ("Atopix"), a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product … |
View full post on asthma – Google News